SHFS vs LGND vs BFIN

For growth investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger pick with 27.

3% revenue growth year-over-year, versus -9. 2% for SHF Holdings, Inc. (SHFS). BankFinancial Corporation (BFIN) offers the better valuation at 36. 4x trailing P/E (15. 2x forward), making it the more compelling value choice. Analysts rate Ligand Pharmaceuticals Incorporated (LGND) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, BankFinancial Corporation is actually cheaper at 15.

2x.

Over the past 5 years, Ligand Pharmaceuticals Incorporated (LGND) delivered a total return of +61.

0%, compared to -99. 8% for SHF Holdings, Inc. (SHFS). Over 10 years, the gap is even starker: LGND returned +73. 0% versus SHFS's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), BankFinancial Corporation (BFIN) is the lower-risk stock at 0.

60β versus SHF Holdings, Inc. 's 1. 87β — meaning SHFS is approximately 210% more volatile than BFIN relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 25% for BankFinancial Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ligand Pharmaceuticals Incorporated (LGND) is pulling ahead at 27.

3% versus -9. 2% for SHF Holdings, Inc. (SHFS). On earnings-per-share growth, the picture is similar: BankFinancial Corporation grew EPS -55. 4% year-over-year, compared to -114. 7% for SHF Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

BankFinancial Corporation (BFIN) is the more profitable company, earning 5.

5% net margin versus -262. 5% for SHF Holdings, Inc. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BFIN leads at 6. 8% versus -24. 2% for SHFS. At the gross margin level — before operating expenses — SHFS leads at 104. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, BankFinancial Corporation (BFIN) trades at 15.

2x forward P/E versus 23. 6x for Ligand Pharmaceuticals Incorporated — 8. 5x cheaper on a one-year earnings basis.

In this comparison, BFIN (3.

3% yield) pays a dividend. SHFS, LGND do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, BankFinancial Corporation (BFIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

60), 3. 3% yield). SHF Holdings, Inc. (SHFS) carries a higher beta of 1. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BFIN: +24. 6%, SHFS: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SHFS (Financial Services) and LGND (Healthcare) and BFIN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SHFS is a small-cap quality compounder stock; LGND is a small-cap high-growth stock; BFIN is a small-cap income-oriented stock. BFIN pays a dividend while SHFS, LGND do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.